NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy

Go back to NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy
(NASDAQ: AKRO) Delayed: 54.74 --0 (-0%)
Previous Close $54.74    52 Week High
Open $54.74    52 Week Low
Day High $54.74    P/E N/A 
Day Low $54.74    EPS
Volume 2,366       

(NASDAQ: NXTC) Delayed: 5.67 -0.36 (5.97%)
Previous Close $6.03    52 Week High
Open $6.05    52 Week Low
Day High $6.38    P/E N/A 
Day Low $5.54    EPS
Volume 106,844